Jochen Reiser Selected Research

pyrintegrin

11/2015

A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jochen Reiser Research Topics

Disease

56	Proteinuria 06/2023 - 08/2004
39	Kidney Diseases (Kidney Disease) 01/2023 - 05/2004
27	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 06/2023 - 07/2005
19	Chronic Renal Insufficiency 11/2023 - 04/2010
17	Inflammation (Inflammations) 04/2024 - 08/2012
10	Infections 08/2023 - 10/2011
9	COVID-19 04/2024 - 01/2020
9	Chronic Kidney Failure (Chronic Renal Failure) 06/2023 - 06/2011
9	Renal Insufficiency (Renal Failure) 06/2023 - 07/2005
9	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2016 - 05/2004
7	Hypertension (High Blood Pressure) 01/2022 - 11/2007
7	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 01/2010
6	Neoplasms (Cancer) 01/2023 - 02/2014
5	Acute Kidney Injury (Acute Renal Failure) 03/2022 - 12/2019
4	Diabetes Mellitus 11/2023 - 01/2014
4	Hyperglycemia 01/2022 - 08/2014
4	Segmental glomerulosclerosis 10/2018 - 09/2010
4	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 10/2018 - 01/2013
4	Albuminuria 01/2018 - 03/2014
3	Cardiotoxicity 02/2024 - 01/2021
3	Wounds and Injuries (Trauma) 08/2023 - 01/2022
3	Disease Progression 01/2023 - 07/2017
3	Fibrosis (Cirrhosis) 12/2021 - 08/2014
3	Critical Illness (Critically Ill) 01/2021 - 12/2019
3	Sclerosis 01/2019 - 01/2015
3	Type 2 Diabetes Mellitus (MODY) 01/2018 - 07/2014
3	Obesity 02/2012 - 03/2011
2	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2024
2	Diabetic Foot 08/2023 - 01/2022
2	Ulcer 08/2023 - 01/2022
2	Venous Thromboembolism 01/2023 - 01/2022
2	Heart Failure 01/2023 - 03/2011
2	Atherosclerosis 12/2022 - 09/2017
2	Melanoma (Melanoma, Malignant) 04/2022 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 05/2017
2	Thrombosis (Thrombus) 01/2017 - 03/2015
2	Lupus Nephritis 01/2014 - 08/2010
2	Nephritis 12/2013 - 09/2011
2	Membranous Glomerulonephritis (Membranous Nephropathy) 12/2013 - 01/2007
2	Insulin Resistance 02/2012 - 03/2011
1	Leukemia 01/2024
1	Lymphoma (Lymphomas) 01/2024
1	Cardiomyopathies (Cardiomyopathy) 01/2024

Drug/Important Bio-Agent (IBA)

32	Urokinase Plasminogen Activator ReceptorsIBA 02/2024 - 12/2012
22	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2001
21	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2023 - 07/2011
19	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2010
11	IntegrinsIBA 01/2023 - 07/2011
11	TRPC6 Cation ChannelIBA 11/2016 - 07/2005
8	CreatinineIBA 11/2023 - 01/2015
6	Dynamins (Dynamin)IBA 01/2022 - 08/2007
6	Rituximab (Mabthera)FDA Link 01/2022 - 06/2011
5	CytokinesIBA 08/2023 - 03/2011
5	Insulin (Novolin)FDA Link 01/2023 - 03/2015
4	LipopolysaccharidesIBA 08/2023 - 01/2008
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2015
4	nephrinIBA 11/2020 - 01/2010
4	Cathepsin LIBA 04/2019 - 08/2004
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2016 - 10/2011
4	Abatacept (Orencia)FDA Link 03/2015 - 01/2014
3	AlbuminsIBA 11/2023 - 07/2014
3	Immune Checkpoint InhibitorsIBA 01/2023 - 04/2022
3	Plasminogen Activators (Plasminogen Activator)IBA 12/2022 - 09/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2012
3	C-Reactive ProteinIBA 01/2022 - 05/2017
3	Protein Isoforms (Isoforms)IBA 01/2021 - 07/2014
3	Puromycin AminonucleosideIBA 10/2018 - 08/2004
3	Calcineurin InhibitorsIBA 11/2013 - 12/2012
3	CalcineurinIBA 12/2012 - 09/2008
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 10/2011
2	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2023 - 01/2022
2	Blood Glucose (Blood Sugar)IBA 01/2023 - 01/2017
2	AnticoagulantsIBA 01/2023 - 03/2022
2	AntibodiesIBA 01/2023 - 01/2023
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 01/2023
2	GTP Phosphohydrolases (GTPases)IBA 01/2022 - 10/2011
2	Cystatin CIBA 01/2022 - 11/2017
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2021 - 11/2007
2	ApolipoproteinsIBA 12/2021 - 01/2020
2	InflammasomesIBA 12/2021 - 01/2020
2	Monoclonal AntibodiesIBA 01/2021 - 01/2020
2	Protein CIBA 01/2020 - 01/2017
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2019 - 01/2015
2	LigandsIBA 01/2019 - 03/2014
2	Sirolimus (Rapamycin)FDA Link 07/2017 - 10/2013
2	Streptozocin (Streptozotocin)FDA Link 01/2017 - 08/2014
2	SteroidsIBA 09/2015 - 11/2013
2	MicroRNAs (MicroRNA)IBA 02/2015 - 08/2014
2	Transient Receptor Potential ChannelsIBA 01/2015 - 09/2010
2	Calcium Channels (Calcium Channel)IBA 12/2013 - 09/2010
2	CationsIBA 01/2007 - 03/2001
1	Parathyroid Hormone (Parathormone)IBA 11/2023
1	omega-Chloroacetophenone (Mace)IBA 11/2023

Therapy/Procedure

19	Therapeutics 01/2023 - 10/2013
8	Kidney Transplantation 06/2023 - 06/2011
6	Transplantation 12/2018 - 04/2010
3	Debridement 08/2023 - 01/2022
3	Immunotherapy 01/2023 - 01/2020
3	Plasma Exchange 12/2018 - 12/2015
2	Renal Dialysis (Hemodialysis) 01/2021 - 08/2017